Article Information
History
- September 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- K.F. Müskens, MD1,
- N. Wieringa, MD1,
- M. van Bergen, PhD2,
- J.E. Bense, MD PhD3,
- B.M. te Pas1,
- A.P.J. de Pagter, MD PhD3,
- A.C. Lankester, MD PhD3,
- M.B. Bierings, MD PhD1,
- D. Neuberg, ScD4,
- S. Haitjema, MD PhD5,
- L.C.M. Kremer, MD PhD1,
- G.A. Huls, MD PhD6,
- S. Nierkens, PhD1,7,
- J.H. Jansen, PhD2,
- C.A. Lindemans, MD PhD1,
- A. de Graaf, PhD2 and
- M.E. Belderbos, MD PhD1,*
- 1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- 2Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
- 3Division of Stem cell Transplantation, Department of Pediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands
- 4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
- 5Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands
- 6Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands
- 7Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
- ↵*Corresponding author:
M.E. Belderbos, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands, Phone: +31 6 26947687, m.e.belderbos{at}prinsesmaximacentrum.nl
Posted September 30, 2024.
Transplantation and old stem cell age independently increase the risk of clonal hematopoiesis in long-term survivors of pediatric HCT
